Minimizing Complications with Radiofrequency Ablation for Liver Cancer: The Importance of Properly Controlled Clinical Trials and Standardized Reporting

Annals of Surgery

Volumn 239, Issue 4, 2004, Pages 459-463

  Helton, W Scott ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MC/958 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EDITORIAL; HONG KONG; HUMAN; LIVER CANCER; PREDICTION; PRIORITY JOURNAL; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; TECHNOLOGY; UNITED STATES;

CATHETER ABLATION; CONTROLLED CLINICAL TRIALS; HUMANS; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 1642322111     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000120150.95389.ba     Document Type: Editorial

References (12)

1. Garcea G, Lloyd TD, Aylott C, et al. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer. 2003;39:2150-2164.
2. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg. 2002;195:378-386.
3. Strasberg SM, Ludbrook PA. Who oversees innovative practice? Is there a structure that meets the monitoring needs of new techniques? J Am Coll Surg. 2003;196:938-948.
4. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1-8.
5. Rhim H, Goldberg SN, Dodd GD III, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21(Spec No):S17-S35; discussion S36-S39.
6. Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335-345.
7. Kettenbach J, Kostler W, Rucklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. Am J Roentgenol. 2003;180:1537-1545.
8. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol. 2002;179:93-101.
9. Sjolie E, Lango T, Ystgaard B, et al. 3D ultrasound-based navigation for radiofrequency thermal ablation in the treatment of liver malignancies. Surg Endosc. 2003;17:933-938.
10. Kobayashi M, Ikeda K, Someya T, et al. Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinoma. Oncology. 2002;63:139-144.
11. Helton WS, Strasberg SM. AHPBA/AJCC Consensus Conference on Staging of Hepatocellular Carcinoma: Rationale and Overview of the Conference. HPB Surg. 2003;5:238-242.
12. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the test-of-time approach. Cancer. 2003;98:2303-2304